137 related articles for article (PubMed ID: 26970663)
1. In vivo phase II-enzymes inducers, as potential chemopreventive agents, based on the chalcone and furoxan skeletons.
Cabrera M; Mastandrea I; Otero G; Cerecetto H; González M
Bioorg Med Chem; 2016 Apr; 24(8):1665-74. PubMed ID: 26970663
[TBL] [Abstract][Full Text] [Related]
2. Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers.
Cabrera M; Lavaggi ML; Croce F; Celano L; Thomson L; Fernández M; Pintos C; Raymondo S; Bollati M; Monge A; López de Ceráin A; Piro OE; Cerecetto H; González M
Bioorg Med Chem; 2010 Jul; 18(14):5391-9. PubMed ID: 20639112
[TBL] [Abstract][Full Text] [Related]
3. Searching phase II enzymes inducers, from Michael acceptor-[1,2]dithiolethione hybrids, as cancer chemopreventive agents.
Couto M; de Ovalle S; Cabrera M; Cerecetto H; González M
Future Med Chem; 2015; 7(7):857-71. PubMed ID: 26061105
[TBL] [Abstract][Full Text] [Related]
4. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
5. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
[TBL] [Abstract][Full Text] [Related]
7. Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity.
Coskun D; Erkisa M; Ulukaya E; Coskun MF; Ari F
Eur J Med Chem; 2017 Aug; 136():212-222. PubMed ID: 28494257
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer.
Srinivasan P; Suchalatha S; Babu PV; Devi RS; Narayan S; Sabitha KE; Shyamala Devi CS
Chem Biol Interact; 2008 Apr; 172(3):224-34. PubMed ID: 18336807
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships in the induction of Phase II enzymes by derivatives of 3H-1,2-dithiole-3-thione in rats.
Munday R; Zhang Y; Munday CM; Li J
Chem Biol Interact; 2006 Mar; 160(2):115-22. PubMed ID: 16458871
[TBL] [Abstract][Full Text] [Related]
11. 1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities.
Fathi MAA; Abd El-Hafeez AA; Abdelhamid D; Abbas SH; Montano MM; Abdel-Aziz M
Bioorg Chem; 2019 Mar; 84():150-163. PubMed ID: 30502626
[TBL] [Abstract][Full Text] [Related]
12. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo.
Chattopadhyay M; Kodela R; Nath N; Street CR; Velázquez-Martínez CA; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):733-40. PubMed ID: 22209714
[TBL] [Abstract][Full Text] [Related]
14. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
O'Dwyer PJ; Clayton M; Halbherr T; Myers CB; Yao Ks
Clin Cancer Res; 1997 May; 3(5):783-91. PubMed ID: 9815750
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles as anti-cancer agents.
Gurupadaswamy HD; Girish V; Kavitha CV; Raghavan SC; Khanum SA
Eur J Med Chem; 2013 May; 63():536-43. PubMed ID: 23535322
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel chalcone-dithiocarbamates as ROS-mediated apoptosis inducers by inhibiting catalase.
Fu DJ; Li JH; Yang JJ; Li P; Zhang YB; Liu S; Li ZR; Zhang SY
Bioorg Chem; 2019 May; 86():375-385. PubMed ID: 30763884
[TBL] [Abstract][Full Text] [Related]
18. Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents.
Rioux B; Pouget C; Fidanzi-Dugas C; Gamond A; Laurent A; Semaan J; Pinon A; Champavier Y; Léger DY; Liagre B; Duroux JL; Fagnère C; Sol V
Bioorg Med Chem Lett; 2017 Sep; 27(18):4354-4357. PubMed ID: 28838697
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and evaluation of chalcone analogues incorporate α,β-Unsaturated ketone functionality as anti-lung cancer agents via evoking ROS to induce pyroptosis.
Zhu M; Wang J; Xie J; Chen L; Wei X; Jiang X; Bao M; Qiu Y; Chen Q; Li W; Jiang C; Zhou X; Jiang L; Qiu P; Wu J
Eur J Med Chem; 2018 Sep; 157():1395-1405. PubMed ID: 30196062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
